Combining Radiotherapy with Chemotherapy and Immunotherapy as First-Line Treatment for De Novo Metastatic Nasopharyngeal Carcinoma: A Dual-Center Retrospective Analysis

被引：0
|
作者：
Ma, L. [1 ,2 ]
Xiang, X. [1 ,2 ]
Lan, F. [1 ,2 ]
Chen, P. [1 ,2 ]
Lei, L. [1 ,2 ]
Zou, T. [1 ,2 ]
Wu, R. [3 ]
Zhang, J. [1 ,2 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Natl Clin Res Ctr Canc, Shenzhen, Guangdong, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen, Guangdong, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Natl Clin Res Ctr Canc,Dept Radiol Oncol, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3321
引用
收藏
页码：E603 / E604
页数：2
相关论文
共 50 条
  • [41] CROSS-REACTIVITY BETWEEN THE FIRST-LINE CHEMOTHERAPY AND SUBSEQUENT IMMUNOTHERAPY IN PATIENTS WITH UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA
    Hamaya, Tomoko
    Hatakeyama, Shingo
    Ozaki, Kai
    Okita, Kazutaka
    Hashimoto, Yasuhiro
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2022, 207 (05): : E1017 - E1017
  • [42] Retrospective analysis of the efficacy of cytokine-induced killer cell immunotherapy combined with first-line chemotherapy in patients with metastatic colorectal cancer
    Pan, Qiu-Zhong
    Gu, Jia-Mei
    Zhao, Jing-Jing
    Tang, Yan
    Wang, Qi-Jing
    Zhu, Qian
    Song, Meng-Jia
    Li, Yong-Qiang
    He, Jia
    Chen, Shi-Ping
    Weng, De-Sheng
    Xia, Jian-Chuan
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (02)
  • [43] Optimal first-line treatment for platinum-eligible metastatic urothelial carcinoma: Comparison of chemo-immunotherapy, immunotherapy, and chemotherapy- A systematic review and meta-analysis
    Li, Haifeng
    Ni, Mengqian
    Xue, Cong
    Li, Lu
    Huang, Riqing
    Yang, Wei
    Hu, Anqi
    An, Xin
    Shi, Yanxia
    CLINICAL IMMUNOLOGY, 2022, 236
  • [44] First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis
    Anton Burkhard-Meier
    Vera Valerie Rechenauer
    Vindi Jurinovic
    Markus Albertsmeier
    Michael Hoberger
    Hans Roland Dürr
    Alexander Klein
    Thomas Knösel
    Wolfgang G. Kunz
    Andreas Mock
    Ada Pusztai
    Michael Völkl
    Michael von Bergwelt-Baildon
    Lars H. Lindner
    Dorit Di Gioia
    Luc M. Berclaz
    Journal of Cancer Research and Clinical Oncology, 151 (4)
  • [45] First-line chemotherapy with gemcitabine in advanced pancreatic cancer: a retrospective single-center analysis
    Magalhaes, H.
    Cassiano Neves, M.
    Fontes e Sousa, M.
    Machado, M.
    Marques, D.
    Faustino, C.
    Sousa, N.
    Ferreira, P.
    Raimundo, A.
    Fragoso, M.
    Luis, M.
    Sales, C.
    ANNALS OF ONCOLOGY, 2015, 26
  • [46] Prognostic value of early radiological response to first-line platinum-containing chemotherapy in patients with metastatic nasopharyngeal carcinoma
    Liu, Guo-Ying
    Li, Wang-Zhong
    Peng, Kang-Qiang
    Lv, Xing
    Ke, Liang-Ru
    Wu, Yi-Shan
    Wang, De-Ling
    Liang, Hu
    Liu, Kui-Yuan
    Lv, Shu-Hui
    Guo, Xiang
    Xiang, Yan-Qun
    Xia, Wei-Xiong
    CANCER MEDICINE, 2020, 9 (03): : 920 - 930
  • [47] Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma
    Chen, Chen
    Zhou, Yixin
    Zhang, Xuanye
    Fu, Sha
    Lin, Zuan
    Fang, Wenfeng
    Yang, Yunpeng
    Huang, Yan
    Zhao, Hongyun
    Hong, Shaodong
    Zhang, Li
    CANCER MEDICINE, 2020, 9 (05): : 1721 - 1732
  • [48] Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Si, Lu
    Li, Siming
    Tang, Bixia
    Mao, Lili
    Lian, Bin
    Wang, Xuan
    Yan, Xieqiao
    Guo, Jun
    ONCOTARGET, 2016, 7 (19) : 27044 - 27054
  • [49] Immunotherapy or targeted therapy as first-line treatment of patients with advanced/metastatic melanoma with the BRAF mutation - a single-center analysis
    Cybulska-Stopa, Bozena
    Piejko, Karolina
    Pacholczak, Renata
    Domagala-Haduch, Malgorzata
    Drosik-Kwasniewska, Anna
    Satek-Zan, Agata
    Wiktor-Mucha, Patrycja
    Rolski, Janusz
    Zemetka, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (04): : 194 - 200
  • [50] Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma A Multicenter Phase 3 Randomized Clinical Trial
    You, Rui
    Liu, You-Ping
    Huang, Pei-Yu
    Zou, Xiong
    Sun, Rui
    He, Yu-Xiang
    Wu, Yi-Shan
    Shen, Guo-Ping
    Zhang, Hong-Dan
    Duan, Chong-Yang
    Tan, Sze Huey
    Cao, Jing-Yu
    Li, Ji-Bin
    Xie, Yu-Long
    Zhang, Yi-Nuan
    Wang, Zhi-Qiang
    Yang, Qi
    Lin, Mei
    Jiang, Rou
    Zhang, Meng-Xia
    Hua, Yi-Jun
    Tang, Lin-Quan
    Zhuang, Ai-Hua
    Chen, Qiu-Yan
    Guo, Ling
    Mo, Hao-Yuan
    Chen, Yong
    Mai, Hai-Qiang
    Ling, Li
    Liu, Qing
    Chua, Melvin Lee Kiang
    Chen, Ming-Yuan
    JAMA ONCOLOGY, 2020, 6 (09) : 1345 - 1352
12345